REGN Earnings

Name: Regeneron Pharmaceuticals, Inc. (REGN) Earnings Call
Start: 2026-10-28

Regeneron Pharmaceuticals, Inc.

Next report

2026-10-28BMOQ3 FY2026Expected date

Quarter	Estimate	Actual	Surprise
Q2 FY2026	10.16	14.29	+40.6%
Q1 FY2026	8.91	9.47	+6.3%
Q4 FY2025	10.74	11.44	+6.5%
Q3 FY2025	9.65	11.83	+22.6%

AI Financial Intelligence
Professional analysis of central bank decisions

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Regeneron Pharmaceuticals, Inc.

2026-10-28BMOQ3 FY2026Expected date

Quarter	Estimate	Actual	Surprise
Q2 FY2026	10.16	14.29	+40.6%
Q1 FY2026	8.91	9.47	+6.3%
Q4 FY2025	10.74	11.44	+6.5%
Q3 FY2025	9.65	11.83	+22.6%

AI Financial Intelligence
Professional analysis of central bank decisions

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.